Lincluden Management LTD Pfizer Inc Transaction History

Lincluden Management LTD

$917 Million
Q3 2024

A detailed history of Lincluden Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Lincluden Management LTD holds 387,108 shares of PFE stock, worth $10.6 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

387,108

Previous 351,854 10.02%

Holding current value

$10.6 Million

Previous $9.85 Million 13.79%

% of portfolio

1.22%

Previous 1.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $976,535 - $1.11 Million	35,254 Added 10.02%	387,108 $11.2 Million
Q2 2024 Jul 24, 2024	SELL	$25.26 - $29.6 $85,277 - $99,929	-3,376 Reduced 0.95%	351,854 $9.85 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $59,883 - $68,765	-2,313 Reduced 0.65%	355,230 $9.86 Million
Q4 2023 Feb 07, 2024	BUY	$26.13 - $33.94 $1.27 Million - $1.65 Million	48,517 Added 15.7%	357,543 $10.3 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $1.05 Million - $1.23 Million	32,684 Added 11.83%	309,026 $10.3 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $35,758 - $41,372	-990 Reduced 0.36%	276,342 $10.1 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $47,268 - $61,536	-1,200 Reduced 0.43%	277,332 $11.3 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $99,740 - $130,200	-2,389 Reduced 0.85%	278,532 $14.3 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $788,292 - $962,307	-18,014 Reduced 6.03%	280,921 $12.3 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $205,569 - $243,741	-4,418 Reduced 1.46%	298,935 $15.7 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $139,537 - $172,904	-3,050 Reduced 1.0%	303,353 $15.7 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $225,194 - $333,812	-5,450 Reduced 1.75%	306,403 $18.1 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $1.83 Million - $2.36 Million	-46,714 Reduced 13.03%	311,853 $13.4 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $750,878 - $850,618	-20,910 Reduced 5.51%	358,567 $14 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $6.7 Million - $7.56 Million	200,029 Added 111.47%	379,477 $13.7 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $253,367 - $322,179	-7,570 Reduced 4.05%	179,448 $6.61 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $190,500 - $223,500	-6,000 Reduced 3.11%	187,018 $6.86 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $346,982 - $420,940	-11,520 Reduced 5.63%	193,018 $6.31 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $708,050 - $1.01 Million	26,195 Added 14.69%	204,538 $6.68 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $529,189 - $600,562	16,075 Added 9.91%	178,343 $6.63 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $11,209 - $14,534	-345 Reduced 0.21%	162,268 $5.53 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $14,607 - $16,400	-395 Reduced 0.24%	162,613 $7.04 Million
Q1 2019 May 16, 2019	SELL	$37.5 - $41.2 $333,000 - $365,856	-8,880 Reduced 5.17%	163,008 $6.92 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $474,142 - $540,574	-12,325 Reduced 6.69%	171,888 $7.12 Million
Q3 2018 Nov 19, 2018	SELL	$34.47 - $41.81 $812,285 - $985,252	-23,565 Reduced 11.34%	184,213 $0
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $62,497 - $66,628	-1,895 Reduced 0.9%	207,778 $7.54 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $81,689 - $94,771	2,560 Added 1.24%	209,673 $0
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $468,300 - $496,883	-14,080 Reduced 6.37%	207,113 $7.5 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $6.86 Million - $7.55 Million	221,193	221,193 $0

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincluden Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lincluden Management LTD with notifications on news.

Account

Lincluden Management LTD Pfizer Inc Transaction History